Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 24374889)

1.

Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ.

Int J Epidemiol. 2014 Feb;43(1):235-48. doi: 10.1093/ije/dyt243. Epub 2013 Dec 27. Review.

2.

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, Hutchinson SJ.

Int J Drug Policy. 2014 Jan;25(1):34-52. doi: 10.1016/j.drugpo.2013.07.001. Epub 2013 Aug 21. Review.

PMID:
23973009
3.

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D.

Addiction. 2010 May;105(5):844-59. doi: 10.1111/j.1360-0443.2009.02888.x. Epub 2010 Mar 2. Review.

PMID:
20219055
4.

Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review.

Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, Kennedy GE, Des Jarlais DC.

AIDS Behav. 2013 Nov;17(9):2878-92. doi: 10.1007/s10461-013-0593-y. Review.

PMID:
23975473
5.

High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.

Des Jarlais DC, Feelemyer JP, Modi SN, Abdul-Quader A, Hagan H.

BMC Public Health. 2013 Jan 19;13:53. doi: 10.1186/1471-2458-13-53. Review.

6.

Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.

Dutta A, Wirtz AL, Baral S, Beyrer C, Cleghorn FR.

Curr Opin HIV AIDS. 2012 Jul;7(4):362-8. doi: 10.1097/COH.0b013e328354a0b5. Review.

PMID:
22647588
7.

Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.

MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, Degenhardt L, Hickman M.

BMJ. 2012 Oct 3;345:e5945. doi: 10.1136/bmj.e5945. Review.

8.

Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts.

Huang YF, Yang JY, Nelson KE, Kuo HS, Lew-Ting CY, Yang CH, Chen CH, Chang FY, Liu HR.

PLoS Med. 2014 Apr 8;11(4):e1001625. doi: 10.1371/journal.pmed.1001625. eCollection 2014 Apr.

9.

Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.

Petersen Z, Myers B, van Hout MC, Pl├╝ddemann A, Parry C.

Harm Reduct J. 2013 Aug 19;10:13. doi: 10.1186/1477-7517-10-13.

10.

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, Parry J, Lyons M, Goldberg D, Allen E, Hickman M.

Addiction. 2011 Nov;106(11):1978-88. doi: 10.1111/j.1360-0443.2011.03515.x. Epub 2011 Aug 24.

PMID:
21615585
11.

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Gillies M, Palmateer N, Hutchinson S, Ahmed S, Taylor A, Goldberg D.

BMC Public Health. 2010 Nov 23;10:721. doi: 10.1186/1471-2458-10-721. Review.

12.

Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).

Strike C, Watson TM, Lavigne P, Hopkins S, Shore R, Young D, Leonard L, Millson P.

Int J Drug Policy. 2011 Jan;22(1):34-40. doi: 10.1016/j.drugpo.2010.03.007. Epub 2010 Apr 22.

PMID:
20413288
13.

What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.

Degenhardt L, Mathers BM, Wirtz AL, Wolfe D, Kamarulzaman A, Carrieri MP, Strathdee SA, Malinowska-Sempruch K, Kazatchkine M, Beyrer C.

Int J Drug Policy. 2014 Jan;25(1):53-60. doi: 10.1016/j.drugpo.2013.08.004. Epub 2013 Sep 4. Review.

PMID:
24113623
14.

Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries.

Zule WA, Cross HE, Stover J, Pretorius C.

Int J Drug Policy. 2013 Jan;24(1):1-7. doi: 10.1016/j.drugpo.2012.07.002. Epub 2012 Aug 10. Review.

PMID:
22884539
15.

Australia's response to HIV among people who inject drugs.

Madden A, Wodak A.

AIDS Educ Prev. 2014 Jun;26(3):234-44. doi: 10.1521/aeap.2014.26.3.234.

PMID:
24846486
16.

Qualitative evaluation of a peer-based needle syringe programme in Vietnam.

Ngo AD, Schmich L, Higgs P, Fischer A.

Int J Drug Policy. 2009 Mar;20(2):179-82. doi: 10.1016/j.drugpo.2007.12.009. Epub 2008 Feb 1.

PMID:
18242971
17.

Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.

Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.

J Urban Health. 2008 May;85(3):309-22. doi: 10.1007/s11524-008-9271-1. Epub 2008 Mar 14.

18.
19.

HIV incidence among injecting drug users in New York City syringe-exchange programmes.

Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, Jose B, Friedman SR.

Lancet. 1996 Oct 12;348(9033):987-91.

PMID:
8855855
20.

Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study.

Islam M, Stern T, Conigrave KM, Wodak A.

Drug Alcohol Rev. 2008 Jan;27(1):13-9.

PMID:
18034377
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk